Hackensack Meridian Health and Carenostics Receive Innovative Practice Award for AI-Driven Tool Used to Diagnose Kidney Disease

Carenostics raises $5 million in Seed funding led by M13

Axios: Carenostics helps clinicians prioritize at-risk patients

M13: Investing in Carenostics: Empowering Clinicians with AI

M13 leads the $5M seed round for Carenostics, a platform deploying life-saving AI to support the treatment of chronic diseases.

BioIT World: Using ML to Diagnose Chronic Kidney Disease in a Bias-Free, Privacy-Protecting, Physician-Friendly Manner

Carenostics Partners with CareJourney to Analyze the Undiagnosis of CKD in the US

Chronic Kidney Disease: The Silent Epidemic of the United States